Pharmacies - Mexico | Statista Market Forecast

The Pharmacies market in Mexico is expected to see a significant increase in revenue, with projections showing it reaching US$13.86bn by 2024.
This growth is expected to continue at a steady pace, with an annual growth rate (CAGR 2024-2029) of 4.09%.
By 2029, the market volume is estimated to reach US$16.94bn.
When compared globally, United States is projected to generate the highest revenue in the Pharmacies market, with an estimated US$387.30bn in 2024.
This highlights the dominance of the US market in this market.
In terms of per person revenue, in Mexico is projected to generate US$107.10 in 2024.
This indicates the average revenue generated per individual in the country's Pharmacies market.
Mexico's pharmacy market is experiencing a surge in demand for over-the-counter medications due to the country's growing middle-class population and increasing healthcare awareness.

Definition:
Pharmacies are physical or digital places where mainly pharmaceuticals and medical products are sold. Additionally, they also sell other items that are generally found in a pharmacy, such as food supplements, cosmetic products, and other health-related goods. A large proportion of pharmaceuticals are only available on prescription; the rest of the product range of pharmacies is sold over the counter (OTC). Besides selling products, pharmacies also advise customers, inform them about undesirable effects of the products, and detect possible interactions with other medicines.

Structure:
The Pharmacies market consists of two markets: Prescriptions Drugs and OTC Products. The Prescription Drugs market covers all products – mainly pharmaceuticals – that are only available on prescription. The OTC Products market comprises all products that are sold over the counter (OTC), including pharmaceuticals, medical devices, and other items that are generally found in a pharmacy.

Additional information:
The KPIs shown include revenue, revenue growth, average revenue per pharmacy, average revenue per capita, number of pharmacies, pharmacy density, users, and the online sales share for the OTC Products market. Revenues are generated through offline and online spending by (B2C) consumers and include VAT. B2B and B2G sales as well as other pharmaceutical sales through hospitals or retail stores, such as supermarkets, are not included.
For more information on the data displayed, use the info button next to the boxes.

Prescription pharmaceuticals
Prescription medical products
OTC pharmaceuticals
OTC medical products
Pharmacy-usual items

Services such as vaccinations
Sales through hospitals or retail stores

The Pharmacies market in Mexico is experiencing significant growth and development in recent years.

Customer preferences: Customers in Mexico prefer to purchase their medications and healthcare products from pharmacies due to the convenience and accessibility they offer. Pharmacies are easily accessible in both urban and rural areas, making it convenient for customers to obtain their medications. Additionally, pharmacies in Mexico often provide a wide range of healthcare products, including over-the-counter medications, vitamins, and personal care items, catering to the diverse needs of customers.

Trends in the market: One major trend in the Pharmacies market in Mexico is the increasing demand for generic medications. Generic medications are more affordable compared to brand-name drugs, making them a popular choice among customers. The Mexican government has also implemented policies to promote the use of generic medications, further driving their demand in the market. Pharmacies in Mexico have responded to this trend by increasing the availability of generic medications, attracting price-conscious customers. Another trend in the market is the growing focus on e-commerce. With the increasing penetration of the internet and smartphones in Mexico, customers are increasingly turning to online platforms to purchase their medications and healthcare products. Pharmacies have recognized this trend and have started to establish their online presence, offering customers the convenience of ordering medications from the comfort of their homes. This trend is expected to continue growing as more customers embrace online shopping.

Local special circumstances: One unique aspect of the Pharmacies market in Mexico is the prevalence of independent pharmacies. These smaller, locally-owned pharmacies play a significant role in meeting the healthcare needs of the population, especially in rural areas where access to healthcare facilities may be limited. Independent pharmacies often have a close relationship with their customers, providing personalized service and building trust. This local presence and personalized service give independent pharmacies a competitive advantage in the market.

Underlying macroeconomic factors: The growth and development of the Pharmacies market in Mexico can be attributed to several underlying macroeconomic factors. Firstly, Mexico has a large and growing population, which creates a substantial demand for healthcare products and medications. Additionally, the increasing prevalence of chronic diseases and the aging population in Mexico contribute to the rising demand for medications. Furthermore, the Mexican government has implemented various healthcare reforms to improve access to healthcare services and medications. These reforms, including the expansion of the Seguro Popular program, have increased the affordability and availability of medications for the population. The government's focus on improving healthcare infrastructure and services also supports the growth of the Pharmacies market. In conclusion, the Pharmacies market in Mexico is experiencing growth and development due to customer preferences for convenience and accessibility, trends such as the demand for generic medications and the rise of e-commerce, the prevalence of independent pharmacies, and underlying macroeconomic factors such as population growth and healthcare reforms. As the market continues to evolve, pharmacies in Mexico will need to adapt to changing customer preferences and embrace technological advancements to remain competitive.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.